Latest Funding News

QuickFee Limited has launched a Share Purchase Plan offering up to 5 million new shares at a 2% discount, aiming to raise $250,000 to fuel loan book growth and strengthen its balance sheet. Neu Capital Australia Pty Ltd has committed to cover any shortfall, underscoring confidence in QuickFee’s growth trajectory.

AusQuest has kicked off a significant drilling campaign at its Morrisey Magnetite Project in Western Australia, aiming to expand on promising iron ore discoveries and assess commercial viability.

Freehill Mining has expanded its footprint in Chile’s La Serena region by securing a third site to increase aggregate production capacity, supporting major infrastructure projects and funding future magnetite mining operations.

GQG Partners has reported a steady rise in funds under management, reaching US$168.5 billion by the end of May 2025, supported by robust net inflows across key equity strategies.

Kore Potash Plc has had its trading suspension lifted following a key announcement about funding for its Kola Project, signaling renewed investor access and potential project momentum.

Kore Potash has signed non-binding term sheets with OWI-RAMS for a $2.2 billion funding package to develop its flagship Kola Potash Project in the Republic of Congo, combining senior secured finance and royalty-based funding under Shariah principles.

Patrys Limited has raised $358,362 through a share placement and announced significant board changes, including the appointment of Dr Anton Uvarov and Mr Peter Christie, alongside making the CEO role redundant.

Finder Energy has spotlighted its Kuda Tasi and Jahal oil development opportunity at the APAC Energy Capital Assembly, revealing a robust resource base and a streamlined development strategy promising rapid returns.

Tempest Minerals has completed a pro-rata entitlement offer, raising over $600,000 to fund exploration in Western Australia, though a significant shortfall remains to be allocated.

VanEck Investments Limited has released a replacement Product Disclosure Statement for its VanEck Bentham Global Capital Securities Active ETF (ASX, GCAP), outlining an actively managed strategy focused on global subordinated debt securities with income and diversification benefits.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Mineral Commodities Ltd reveals delays in receiving the final payment for its Skaland Graphite Project sale, with interest rates on outstanding amounts now sharply increased.